Mainz Biomed N.V. (QUCY)
NASDAQ: QUCY · Real-Time Price · USD
0.4751
+0.0170 (3.71%)
Apr 6, 2026, 4:00 PM EDT - Market closed

Mainz Biomed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
3.323.320.360.680.130.38
Debt / EBITDA Ratio
-0.17-0.17-0.19-0.29-0.12-0.27
Debt / FCF Ratio
-0.23-0.23-0.20-0.32-0.21-0.80
Net Debt / Equity Ratio
2.622.62-0.450.11-0.99-0.97
Net Debt / EBITDA Ratio
-0.11-0.110.15-0.010.530.64
Net Debt / FCF Ratio
-0.15-0.150.16-0.010.901.90
Asset Turnover
0.060.060.060.050.030.11
Inventory Turnover
0.500.500.650.983.96-
Quick Ratio
0.260.261.020.784.066.54
Current Ratio
0.500.501.300.974.337.11
Return on Equity (ROE)
-488.32%-488.32%-467.15%-303.20%-257.98%-645.93%
Return on Assets (ROA)
-171.43%-171.43%-129.87%-149.48%-174.65%-181.53%
Return on Invested Capital (ROIC)
-412.73%-412.73%-408.71%-1017.80%-8934.31%-5977.24%
Return on Capital Employed (ROCE)
-360.52%-360.52%-278.30%-240.36%-214.23%-224.58%
Buyback Yield / Dilution
-508.38%-508.38%-142.75%-14.73%-96.33%-28.60%
Total Shareholder Return
-508.38%-508.38%-142.75%-14.73%-96.33%-28.60%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q